SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-15-056791
Filing Date
2015-06-26
Accepted
2015-06-26 16:05:22
Documents
2
Period of Report
2015-06-24

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4325
2 EX-24 DOCUMENT attachment1.htm EX-24 4559
  Complete submission text file 0001209191-15-056791.txt   10320
Mailing Address 131 HARTWELL AVE 1ST FLOOR, SUITE 105 LEXINGTON MA 02421
Business Address 131 HARTWELL AVE 1ST FLOOR, SUITE 105 LEXINGTON MA 02421 781-676-2100
INOTEK PHARMACEUTICALS CORP (Issuer) CIK: 0001281895 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O INOTEK PHARMACEUTICALS CORPORATION 131 HARTWELL AVENUE, SUITE 105 LEXINGTON MA 02421
Business Address
Baumgartner Rudolph (Reporting) CIK: 0001632878 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36829 | Film No.: 15955122